These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 14577673)

  • 1. Multiple congenital malformations including generalized hypertrichosis with gum hypertrophy in a child exposed to valproic acid in utero.
    Stoll C; Audeoud F; Gaugler C; Bernardin A; Messer J
    Genet Couns; 2003; 14(3):289-98. PubMed ID: 14577673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.
    Kozma C
    Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Embryopathy due to valproic acid with severe malformations in the central nervous system].
    Pardal-Fernández JM; Carrascosa-Romero MC; Rodríguez-Vázquez M; Marco-Giner J; Martínez-Gutiérrez A
    Rev Neurol; 2006 Mar 16-31; 42(6):336-40. PubMed ID: 16575769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of fetal valproate syndrome with new features expanding the phenotype.
    Al-Mendalawi MD; Seidahmed MZ
    Saudi Med J; 2009 Jul; 30(7):977; author reply 977-8. PubMed ID: 19618023
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital abnormalities in two sibs exposed to valproic acid in utero.
    Chitayat D; Farrell K; Anderson L; Hall JG
    Am J Med Genet; 1988 Oct; 31(2):369-73. PubMed ID: 3148279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fetal valproate syndrome].
    Sonoda T
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):96-8. PubMed ID: 11057157
    [No Abstract]   [Full Text] [Related]  

  • 7. [The first case of a child born with fetal valproic acid syndrome in Hungary].
    Robinek F; Czeizel E
    Orv Hetil; 1989 Jan; 130(5):267. PubMed ID: 2492655
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate and gum hypertrophy.
    Gulati S; Thukral A
    Indian Pediatr; 2004 Oct; 41(10):1059. PubMed ID: 15523136
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of fetal valproate syndrome with new features expanding the phenotype.
    Seidahmed MZ; Miqdad AM; Al-Dohami HS; Shareefi OM
    Saudi Med J; 2009 Feb; 30(2):288-91. PubMed ID: 19198722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.
    Viinikainen K; Eriksson K; Mönkkönen A; Aikiä M; Nieminen P; Heinonen S; Kälviäinen R
    Epilepsy Behav; 2006 Dec; 9(4):636-40. PubMed ID: 17049311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.
    Hockey A; Bower C; Goldblatt J; Knowles S
    Birth Defects Orig Artic Ser; 1996; 30(1):401-5. PubMed ID: 9125345
    [No Abstract]   [Full Text] [Related]  

  • 13. Congenital marked hypertrichosis and Laband syndrome in a child: overlap between the gingival fibromatosis-hypertrichosis and Laband syndromes.
    Lacombe D; Bioulac-Sage P; Sibout M; Daussac E; Lesure F; Manchart JP; Battin J
    Genet Couns; 1994; 5(3):251-6. PubMed ID: 7811425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias.
    Nicolai J; Vles JS; Aldenkamp AP
    J Neurol Sci; 2008 Aug; 271(1-2):1-14. PubMed ID: 18479711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe bone malformations in fetal valproic acid disease].
    Lorenzo Sanz G; Serna Saugar C; Quintana Castilla A; Lozano Giménez C; Aparicio Meix JM
    An Esp Pediatr; 1993 Jul; 39(1):19-21. PubMed ID: 8363144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A child with a DIC (15p; 22p) centric fusion and fetal Valproate syndrome.
    Sharief N; Adams T; Butler L; Gnanaratnam J
    Indian Pediatr; 1999 May; 36(5):507-10. PubMed ID: 10728044
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information.
    Martínez-Frías ML
    Am J Med Genet; 1990 Oct; 37(2):277-82. PubMed ID: 2248297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring.
    Artama M; Auvinen A; Raudaskoski T; Isojärvi I; Isojärvi J
    Neurology; 2005 Jun; 64(11):1874-8. PubMed ID: 15955936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.